Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hematologic Diseases × Exercise × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 201 Breast Neoplasms 111 Neoplasms 88 Prostatic Neoplasms 33 Fatigue 28 Obesity 22 Colorectal Neoplasms 19 Lung Neoplasms 16 Colonic Neoplasms 15 Polycystic Ovary Syndrome 14 Ovarian Neoplasms 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Lymphoma 10 Lymphedema 10 Head and Neck Neoplasms 10 Rectal Neoplasms 9 Weight Loss 8 Multiple Myeloma 8 Leukemia 8 Hematologic Neoplasms 8 Cardiotoxicity 8 Pancreatic Neoplasms 7 Insulin Resistance 7 Carcinoma, Non-Small-Cell Lung 7 Cognitive Dysfunction 6 Brain Neoplasms 6 Overweight 5 Inflammation 5 Cachexia 5 Stomach Neoplasms 4

Interventions

fludarabine 11 Cyclophosphamide 10 Busulfan 8 Mycophenolic Acid 6 fludarabine phosphate 5 Whole-Body Irradiation 5 Tacrolimus 5 Melphalan 5 Dexamethasone 5 Granulocyte Colony-Stimulating Factor 4 Thiotepa 3 Sirolimus 3 Rituximab 3 Methotrexate 3 Cyclosporine 3 Blood Specimen Collection 3 Alemtuzumab 3 pomalidomide 2 pembrolizumab 2 isatuximab 2 Vorinostat 2 Stem Cell Transplantation 2 Platelet Transfusion 2 Lenalidomide 2 Interviews as Topic 2 Filgrastim 2 Etoposide 2 Carmustine 2 Bortezomib 2 Bone Marrow Transplantation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03886909 2023-07-11

IMPROVE-BMT

Milton S. Hershey Medical Center

Phase NA Completed

Hematologic Diseases, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡